RxDoctor Payments Data

Abraham Jaguan, MD

Otolaryngology · Miami, FLNPI 1487654950

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,001 of the $4,769 with a category attached, or 62.9%. 19 manufacturers reported payments, led by Intersect ENT, Inc. at 58.6% of the total. Reporting peaked in 2019 at $2,828 and has fallen 84.0% since, to $453 in 2025.

$4,769in general payments, 2019–2025

Across 65 payments — averaging $73.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$3K
  • Stryker$607
  • Cochlear Americas$499
  • Medtronic$156
  • Amniox Medical, Inc.$125
  • GSK$94
  • plus $494 from 13 others
$69,515in research payments, 2019–2025

Across 5 payments — averaging $13,903 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$70K

What the payments were for

  • Consulting fees$752%
  • Travel & lodging$1,69336%
  • Food & beverage$3,00163%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,769 in reported general payments places this provider in the 75th percentile of 586 otolaryngology providers in Florida.

See all otolaryngology providers in Florida

Medicare billing

Part B allowed, 2024
$155,632
Medicare patients
429
Services billed
4,162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl222$7,908
Fluticasone Propionate535$7,135
Fluocinolone Acetonide Oil105$5,329
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth40$4,295
Fml ForteFluorometholone12$4,097
Ofloxacin91$3,735
Fluorometholone29$2,465
Ipratropium Bromide76$1,844
Famotidine131$967
Omeprazole101$935
Prednisolone Acetate15$553
Mometasone Furoate33$511
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav32$402
Mupirocin66$399
Clarithromycin14$382

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →